Pfizer gets an A on equality scorecard on Equal Pay Day

By Sharon Klahr Coey, March 21, 2022 - On Tuesday, March 15, Equal Pay Day, Arjuna Capital and Proxy Impact released the fifth Racial and Gender Pay Scorecard, and, surprise—women and people of color are still being paid less than their white male counterparts.

However, one pharma, namely Pfizer, is getting an A when it comes to quantitative disclosures in relation to closing racial and gender pay gaps. Unfortunately, the other pharma on the list, Biogen, received an F, and while this doesn’t necessarily mean it is failing, it does mean the company has refused to disclose its quantitative data on the subject. This, of course, usually isn’t a good sign.

Click here to read the full article.

Equal Pay, Gender Pay Equity, Gender Equality, Gender DiscriminationIsabelle BhayaniEqual Pay Day, equality, gender pay gap, gender equity, gender pay parity, gender pay equity, Pfizer, Arjuna Capital, Proxy Impact, gender pay scorecard